Seeking Alpha

Alcobra Ltd. (ADHD)

Show Summaries  |  Hide Summaries
Visit Seeking Alpha's
ADHD vs. ETF Alternatives
Company Description
Alcobra Ltd is a biopharmaceutical company which engaged in the development and commercialization of its proprietary oral drug candidate, MDX, to treat ADHD and other cognitive dysfunctions including Fragile X Syndrome.
Sector: Healthcare
Country: Israel